iHuman (IH) Research & Development (2019 - 2026)

iHuman (IH) has reported Research & Development for 8 consecutive years, with -$8.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development fell 7.32% year-over-year to -$8.2 million; the TTM figure through Mar 2026 stood at -$29.8 million (up 8.8% YoY), while the FY2025 annual figure was $25.9 million, down 14.62% from the prior year.
• Research & Development retreated to -$8.2 million in Q1 2026 per IH's latest filing, from -$6.4 million in the prior quarter.
• Across five years, Research & Development topped out at -$6.4 million in Q4 2025 and bottomed at -$15.2 million in Q1 2022.
• Historically, Research & Development has averaged -$9.1 million across 5 years, with a median of -$8.7 million in 2023.
• On a YoY basis, Research & Development climbed as much as 50.35% in 2022 and fell as far as 21.61% in 2022.
• iHuman's Research & Development stood at -$9.7 million in 2022, then advanced by 3.59% to -$9.3 million in 2023, then rose by 7.11% to -$8.7 million in 2024, then climbed by 25.92% to -$6.4 million in 2025, then declined by 27.49% to -$8.2 million in 2026.
• Business Quant data shows IH's Research & Development at -$8.2 million in Q1 2026, -$6.4 million in Q4 2025, and -$7.8 million in Q3 2025.